Patents by Inventor Jacobus Van Der Linden

Jacobus Van Der Linden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060229352
    Abstract: Disclosed are novel amino acid derivatives of formula (I) and (II) processes for the preparation thereof, and their use in the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino-[4,5-c]pyrrole.
    Type: Application
    Filed: April 6, 2006
    Publication date: October 12, 2006
    Applicants: Organon Ireland Ltd., Pfizer Inc.
    Inventors: Gerardus Kemperman, Jacobus Van Der Linden, Michael Reeder
  • Patent number: 6517829
    Abstract: New products are provided comprising inactivated lower eukaryotic cells, preferably yeasts or molds, having at the outer surface functionally active antibodies or functionally active fragments thereof. Preferred antibody fragments are the variable domains of Camelidae heavy chain antibodies, which are surprisingly stable against physical and chemical decontamination regimes and do not loose their activity when they are immobilized on the glucan layer of the cell wall which is present in a variety of lower eukaryotes. The new products are preferably in the field of food products, personal care products, and animal feed products.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: February 11, 2003
    Assignee: Unilever Patent Holdings BV
    Inventors: Leon Gerardus Joseph Frenken, Michael Marie Harmsen, Richard Hendricus Jacobus van der Linden, Cornelis Theodorus Verrips